Shawnte Mitchell serves as Executive at Aptevo Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Shawnte Mitchell has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 7, 2022 involved transacting 605 shares valued at $0.
Shawnte Mitchell currently holds 80,527 shares of Aptevo Therapeutics Inc. (APVO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Shawnte Mitchell has been a net neutral trader of APVO stock. They have purchased $0 and sold $0 worth of shares.
Shawnte Mitchell's most recent insider trade was on Mar 7, 2022, when they sold 605 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $1.57 |
| Discretionary |
| Mar 1, 2019 | APVO | $0 | Option Exercise | 6,787 | $N/A | Discretionary |
| Aug 9, 2018 | APVO | $1.7K | Payment | 383 | $4.50 | Discretionary |
| Aug 9, 2018 | APVO | $0 | Option Exercise | 1,630 | $N/A | Discretionary |